Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?
Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating ...
Ticker: Biogen Alzheimer’s drug gets second look in EU; Ford takes $165M hit on slow recall
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
The Business Journals27d
Cambridge biotech's layoffs will cut dozens of Mass. employees
In a filing Friday, it said how many of those cut are Massachusetts ... Biogen had also applied to market it as a treatment for. In its recent third-quarter earnings call, Sage said the two ...
Nature5y
Milestones in multiple sclerosis: Biogen’s commitment to advancing the field
As an independent biotechnology company, Biogen (Cambridge, MA) has led innovation in treatment and outcomes assessment in MS for >25 years and continues to have an enduring commitment to elevate ...
Nasdaq1mon
Biogen's Q3 2024 Earnings: What to Expect
Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. With a market cap of $26.6 bi ...
Seeking Alpha27d
Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
Biogen Inc. (NASDAQ:BIIB) the central nervous system disease drug developer based in Cambridge Massachusetts, reported its Q3 earnings yesterday, Wednesday, October 30. First, let's look at some ...
pharmaphorum1y
Biogen taps Envisagenics' AI to speed up RNA splicing R&D
Biogen has made a further push into RNA ... RNA sequencing data to discover new drug targets and therapeutics. Cambridge, Massachusetts-based Envisagenics focuses on using AI to analyse errors ...
Investing22d
Biogen's SWOT analysis: stock outlook amid pipeline challenges, market shifts
Biogen, headquartered in Cambridge, Massachusetts, has established itself as a key player in the biopharmaceutical industry, focusing on innovative therapies for neurological conditions.
CNN1y
Biogen Inc.
Biogen, Inc. is a biopharmaceutical company ... and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Yahoo Finance29d
Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth
the Cambridge, Massachusetts-based company said Wednesday in a statement. While that’s a 6% decline from a year earlier, it beat analysts’ estimates. The results could help Biogen start to ...
Nature3y
Modifying the course of Alzheimer’s disease: Biogen and Eisai perspectives
Ivana Rubino works at Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States. Bruce Albala works at Eisai, Inc., 100 Tice Boulevard, Woodcliff Lake ...